| pubmed-article:20108339 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20108339 | lifeskim:mentions | umls-concept:C0003993 | lld:lifeskim |
| pubmed-article:20108339 | lifeskim:mentions | umls-concept:C1720825 | lld:lifeskim |
| pubmed-article:20108339 | lifeskim:mentions | umls-concept:C0442711 | lld:lifeskim |
| pubmed-article:20108339 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20108339 | pubmed:dateCreated | 2010-4-20 | lld:pubmed |
| pubmed-article:20108339 | pubmed:abstractText | On a voluntary basis therapeutic drug monitoring (TDM) was implemented in the ALL-BFM 2000 protocol for the three currently used asparaginase (ASNase) preparations (first line: native Escherichia coli ASNase; second line: pegylated ASNase and third line: Erwinia chrysanthemi ASNase). | lld:pubmed |
| pubmed-article:20108339 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20108339 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20108339 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20108339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20108339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20108339 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20108339 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20108339 | pubmed:issn | 1545-5017 | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:HempelGeorgG | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:BoosJoachimJ | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:SchrappeMarti... | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:Lanvers-Kamin... | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:GerssJoachimJ | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:MörickeAnjaA | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:SchreyDominik... | lld:pubmed |
| pubmed-article:20108339 | pubmed:author | pubmed-author:BorghorstStep... | lld:pubmed |
| pubmed-article:20108339 | pubmed:copyrightInfo | Copyright 2010 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:20108339 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20108339 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:20108339 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:20108339 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20108339 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20108339 | pubmed:pagination | 952-8 | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:meshHeading | pubmed-meshheading:20108339... | lld:pubmed |
| pubmed-article:20108339 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20108339 | pubmed:articleTitle | Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007. | lld:pubmed |
| pubmed-article:20108339 | pubmed:affiliation | Department of Paediatric Haematology and Oncology, University Hospital Muenster, Muenster, Germany. | lld:pubmed |
| pubmed-article:20108339 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20108339 | pubmed:publicationType | Multicenter Study | lld:pubmed |
